Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions

Peritoneal Dialysis International

Volumn 22, Issue 5, 2002, Pages 593-601

  Zakaria, El Rasheid ^a   Spain, David A ^a   Harris, Patrick D ^a   Garrison, R Neal ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Aquaporins; Endothelial dependent hyperpolarizing factor; Hyperosmolality; Nitric oxide; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; BUFFER; GLUCOSE; ISOPRENALINE; LACTIC ACID; NITROPRUSSIDE SODIUM; PERITONEAL DIALYSIS FLUID; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HEMODYNAMICS; HYPEROSMOLALITY; ILEUM; IN VIVO STUDY; INTESTINE BLOOD FLOW; LABORATORY; MALE; MICROSCOPY; MICROVASCULATURE; NONHUMAN; PERMEABILITY; PH; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; VASODILATATION; VEIN BLOOD FLOW; VENULE;

EID: 0036755654     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200510     Document Type: Article

References (42)

1. Wieslander AP, Kjellstrand PT, Rippe B. Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations. Perit Dial Int 1995; 15(7):S52-9.
2. Simonsen O, Wieslander A, Landgren C, Rippe B. Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid. Adv Perit Dial 1996; 12:156-60.
3. Van Bronswijk H, Verbrugh HA, Bos HJ, Heezius EC, Oe PL, van der Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
4. Van Bronswijk H, Verbrugh HA, Heezius EC, Verkooyen RP, van der Meulen J, Verhoef J. Host defence in CAPD treatment: the effect of the dialysate on cell function. Contrib Nephrol 1990; 85:67-72.
5. Lindholm B, Bergström J. Nutritional aspects on peritoneal dialysis. Kidney Int Suppl 1992; 38:S165-71.
6. Miller FN, Nolph KD, Harris PD, Rubin J, Wiegman DL, Joshua IG, et al. Microvascular and clinical effects of altered peritoneal dialysis solutions. Kidney Int 1979; 15:630-9.
7. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. Kidney Int 1981; 20:397-402.
8. Mellander S, Johansson B, Gray S, Jonsson O, Lundvall J, Ljung B. The effect of hyperosmolarity on intact and isolated vascular smooth muscle. Possible role in exercise hyperemia. Angiologica 1967; 4:310-22.
9. Gazitua S, Scott JB, Swinhoe B, Haddy FJ. Resistance response to local changes in plasma osmolality in three vascular beds. Am J Physiol 1971; 220:384-91.
10. Levine SE, Granger DN, Brace RA, Taylor AW. Effect of hyperosmolality on vascular resistance and lymph flow in the cat ileum. Am J Physiol 1978; 234:H14-20.
11. Miller FN, Joshua IG, Harris PD, Wiegman DL, Jauchem JR. Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol 1979; 17:51-8.
12. Miller FN, Wiegman DL, Joshua IG, Nolph KD, Rubin J. Effects of vasodilators and peritoneal dialysis solution of the microcirculation of the rat cecum. Proc Soc Exp Biol Med 1979; 161:605-8.
13. Rubin J, Nolph KD, Arfania D, Joshua IG, Miller FN, Wiegman DL, et al. Clinical studies with a nonvasoactive peritoneal dialysis solution. J Lab Clin Med 1979; 93:910-15.
14. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN. Selective microvascular endothelial cell dysfunction in the small intestine following resuscitated hemorrhagic shock. Shock 1998; 10:417-22.
15. Cryer HM, Garrison RN, Kaebnick HW, Harris PD, Flint LM. Skeletal microcirculatory responses to hyperdynamic Escherichia coli sepsis in unanesthetized rats. Arch Surg 1987; 122:86-92.
16. Lubbe AS, Garrison RN, Cryer HM, Alsip NL, Harris PD. EDRF as a possible mediator of sepsis-induced arteriolar dilation in skeletal muscle. Am J Physiol 1992; 262:880-7.
17. Zhao H, Spain DA, Matheson PJ, Vaughn C, Harris PD, Garrison RN. Sustained infection induces 2 distinct microvascular mechanisms in the splanchnic circulation. Surgery 2000; 128:513-19.
18. Morff RJ, Harris PD, Wiegman DL, Miller FN. Muscle microcirculation: effects of tissue pH, PCO2, and PO2 during systemic hypoxia. Am J Physiol 1981; 240: 746-54.
19. Faber JE, Harris PD, Miller FN. Microvascular sensitivity to PGE2 and PGI2 in skeletal muscle of decerebrate rat. Am J Physiol 1982; 243:844-51.
20. Alsip NL, Harris PD. Receptor mediation of microvascular responses to serotonin in striated muscle. Am J Physiol 1991; 261:1525-33.
21. Fleming JT, Harris PD, Joshua IG. Endogenous prostaglandins selectively mask large arteriole constriction to angiotensin II. Am J Physiol 1987; 253:1573-80.
22. Lubbe AS, Garrison RN, Harris PD. Endothelium-dependent microvascular responses to activated complement. J Surg Res 1994; 57:654-60.
23. Bohlen HG, Gore RW. Preparation of rat intestinal muscle and mucosa for quantitative microcirculatory studies. Microvasc Res 1976; 11:103-10.
24. Bakker EN, Sipkema P. Components of acetylcholine induced dilation in isolated rat arterioles. Am J Physiol 1997; 273:H1848-53.
25. Lipowsky HH, Zweifach BW. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 1978; 15:93-101.
26. White R, Barefield D, Ram S, Work J. Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney Int 1995; 48:1986-93.
27. White R, Ram S. Peritoneal dialysis solution attenuates microvascular leukocyte adhesion induced by nitric oxide synthesis inhibition. Adv Perit Dial 1996; 12:53-6.
28. Massett MP, Koller A, Kaley G. Hyperosmolality dilates rat skeletal muscle arterioles: role of endothelial K(ATP) channels and daily exercise. J Appl Physiol 2000; 89:2227-34.
29. + channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular beds. J Pharmacol Exp Ther 1997; 282:1473-9.
30. McCulloch AI, Randall MD. Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol 1998; 123:1700-6.
31. Nishikawa Y, Stepp DW, Chilien WM. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation. Am J Physiol 1999; 277:1252-9.
32. Petersson J, Zygmunt PM, Hogestatt ED. Characterization of the potassium channels involved in EDHF-mediated relaxation in cerebral arteries. Br J Pharmacol 1997; 120:1344-50.
33. Tare M, Parkington HC, Coleman HA. EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br J Pharmacol 2000; 130:605-18.
34. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262:H611-15.
35. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 1995; 2:235-44.
36. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396:269-72.
37. Matheson PJ, Spain DA, Harris PD, Garrison RN, Wilson MA. Glucose and glutamine gavage increase portal vein nitric oxide metabolite levels via adenosine A2b activation. J Surg Res 1999; 84:57-63.
38. Douma CE, de Waart DR, Struijk DG, Krediet RT. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 1997; 51:1885-92.
39. Douma CE, Zweers MM, de Waart DR, van der Wardt AB, Krediet RT, Struijk DG. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits. Perit Dial Int 1999; 19:358-64.
40. Flessner MF, Lofthouse J, Zakaria ER. Improving contact area between the peritoneum and intraperitoneal therapeutic solutions. J Am Soc Nephrol 2001; 12: 807-13.
41. Zakaria ER, Carlsson O, Rippe B. Limitation of small-solute exchange across the visceral peritoneum: effects of vibration. Perit Dial Int 1997; 17:72-9.
42. Levitt MD, Kneip JM, Overdahl MC. Influence of shaking on peritoneal transfer in rats. Kidney Int 1989; 35:1145-50.